| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,473,100 | 2,724,300 | 3,502,500 | 3,905,700 | | Cost of Revenue | 2,002,500 | 2,245,500 | 2,918,400 | 3,258,300 | | | Gross Profit | 470,600 | 478,800 | 584,100 | 647,400 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 361,100 | 391,800 | 443,000 | 493,600 | | Non Recurring |
-
|
-
| 1,756,500 |
-
| | Others | 20,700 | 22,400 | 22,500 | 22,400 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 88,800 | 64,600 | (1,637,900) | 131,400 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 10,600 | 38,200 | 10,800 | 1,200 | | Earnings Before Interest And Taxes | 99,400 | 102,800 | (1,627,100) | 132,600 | | Interest Expense | 21,900 | 41,300 | 40,300 | 43,100 | | Income Before Tax | 77,500 | 61,500 | (1,667,400) | 89,500 | | Income Tax Expense | 28,900 | (9,200) | (262,800) | 36,700 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 48,600 | 70,700 | (1,404,600) | 52,800 | | | Non-recurring Events | | Discontinued Operations | (14,000) | (3,600) | (8,100) | (1,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 34,600 | 67,100 | (1,412,700) | 51,800 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $34,600 | $67,100 | ($1,412,700) | $51,800 |
|
0.45% Nasdaq 
0.20%
Income Statement
